Do GLP-1 weight loss injections work long term?
If you’re using (or thinking about using) GLP-1 weight loss injections, one question almost always comes up:
“What happens when I stop? Will the weight just come back?”
In early 2026, a large study published in The BMJ (British Medical Journal) looked closely at this exact question. The findings can help doctors and patients set realistic expectations - and they highlight why planning for the long term matters!
What did the BMJ study look at?
Researchers reviewed results from dozens of studies involving people who used weight-management medications (including GLP-1–based treatments), and then followed what happened after the medication was stopped.
Rather than focusing on brand names, the researchers looked at the overall pattern of weight change once treatment ended.
So… does the weight come back?
The short answer
For many people, yes — some weight regain is common after stopping.
What the averages showed
Across all weight-loss medicines studied , people regained weight at an average rate of about:
-
0.4 kg per month after stopping
For newer, more potent GLP-1 injections, the average regain was faster — closer to:
-
0.8 kg per month
Using modelling, the researchers estimated that many people’s weight gradually returned toward their starting weight within 1.5–2 years after stopping.
These are averages, not guarantees — some people regain less, some more.
What about blood sugar, cholesterol and blood pressure?
While people were taking medication, health markers like blood sugar, cholesterol and blood pressure generally improved.
After stopping, the study found these benefits tended to fade over time, gradually drifting back toward previous levels.
This doesn’t mean the medications aren’t helpful — it means their benefits are closely linked to ongoing treatment or ongoing support.
Does this mean GLP-1 injections “don’t work”?
Not at all.
These medications can be very effective while you’re taking them. What the study highlights is something doctors already see in practice:
Weight regulation is long term. Short-term treatment rarely leads to permanent change on its own.
This is similar to conditions like high blood pressure or diabetes — stopping treatment often means the condition returns.
Why does weight regain happen after stopping?
GLP-1–based medicines work by changing appetite signals and satiety. When they’re stopped:
-
Hunger signals often return
-
Eating patterns may gradually shift
-
Old habits can creep back in, especially during stress or busy periods
This isn’t a lack of willpower — it’s biology.
Is lifestyle still important?
Yes — but the BMJ review found something interesting.
When researchers compared people stopping medication with people finishing structured lifestyle programs, weight regain after medication tended to be faster.
One explanation is that lifestyle programs often teach skills people continue using, while medication does some of the work for you — which means planning for what happens next is crucial. And if you can combine sustainable lifestyle changes with medications, you will most likely fare better in the long run.
What does a “good long-term plan” look like?
From a GP perspective, the people who tend to do best usually:
-
Understand that maintenance is a phase
-
Build routines around:
-
sleep and stress management
-
Have regular check-ins, especially if changing or stopping treatment
-
Plan for cost, access, and life changes in advance
Some people stay on treatment longer, or maybe cut down to a low maintenance dose. Others stop but keep strong support structures in place. There’s no single “right” approach — but stopping without a plan is rarely ideal.
Common questions patients ask
Will everyone regain weight after stopping GLP-1 injections?
No. But on average, many people do regain some weight, and often more quickly than expected.
Does that mean I need to stay on treatment forever?
Not necessarily. Some people use treatment longer term; others transition off with a clear maintenance strategy. It’s an individual decision made with your doctor.
If weight comes back, have I failed?
No. Weight regain is common and reflects how the body regulates appetite — it is not personal failure.
The bottom line
GLP-1 weight loss injections can be powerful tools — but they work best when used as part of a long-term plan, not a short-term fix.
If you’re considering starting, stopping, or adjusting treatment, the most important step is having an open conversation with a clinician about what comes next — not just what happens during the first few months.
References & further reading
Main Study
-
BMJ 2026 systematic review — Weight regain after stopping weight-management medication
Weight regain after cessation of medication for weight management: systematic review and meta-analysis (BMJ) — This is the primary research article in The BMJ that analysed 37 studies and found weight regain after GLP-1 weight loss medicines stop.
News & Context Summaries
-
University of Oxford summary of the BMJ findings
New study finds that stopping weight‑loss drugs is linked to faster regain than ending diet programmes (Oxford) — An accessible, evidence-based overview of the BMJ review’s main messages. -
Science Media Centre briefing
Weight regain after stopping obesity drugs, new systematic review and meta‑analysis (Science Media Centre) — Independent briefing summarising the key findings (weight regain rates and cardiometabolic trends). -
News-Medical summary
Most patients regain lost weight within two years of stopping obesity drugs (News‑Medical) — A clear reporting of the study’s core conclusions for a clinical audience.
Additional Resources
-
Injectable drugs for weight management — Australian Prescriber — Clinical overview of how GLP-1 and dual incretin medicines work, their role in weight management, and the need for integrated care. Injectable drugs for weight management (Australian Prescriber)
-
Pharmacotherapy for the management of overweight and obesity — Australian Journal of General Practice (AJGP) — Overview of the role of pharmacotherapy as an adjunct to lifestyle in overweight and obesity in Australian practice. Pharmacotherapy for overweight and obesity (AJGP)
-
RACGP – Pharmacotherapy for obesity (AFP / general practice guidance) — Discussion of obesity as a chronic disease and the role of pharmacotherapy alongside lifestyle interventions. Pharmacotherapy for obesity (RACGP / AFP)
